tirzepatide weight loss clinical trial results Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: from the Phase 3 SURMOUNT-2 | Diabetes Therapy tirzepatide weight loss clinical trial

Her family history of type 2 diabetes, which is closely associated with obesity, is big part of why she wants to lose weight and keep it off

Bloating on a GLP-1 medication is driven by delayed gastric emptying, which a probiotic does not reverse

People with rheumatoid arthritis consistently had lower levels of vitamin D in their blood than those without arthritis when studied

Gastric emptying scintigraphy remains the primary imaging modality for evaluating symptoms of gastroparesis such as abdominal pain, bloating, nausea, loss of appetite, and more, study lead author Rutger Gunther, MD, from the Uniformed Services University of the Health Sciences, said in a statement

Your provider must also review all current medications and supplements for potential interactions

Bone (2002) 30(1):30713.10.1016/S8756-3282(01)00662-7 17 Nuche-BerenguerBMorenoPEsbritPDapiaSCaeiroJRCancelasJet alEffect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states